Drug target · CHRNA7
alpha7 nAChR
Nicotinic acetylcholine receptor alpha7 subunit
3 compounds in the CNS pipeline act on alpha7 nAChR.
Compounds targeting alpha7 nAChR
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| VQW-765primarySmall molecule | Partial agonist | EC50 7.5 uM | Phase 3Social anxiety disorder | Vanda Pharmaceuticals Inc. |
| BNC210 (soclenicant)primarySmall molecule | NAM | — | Phase 2Post-traumatic stress disorder | Neuphoria Therapeutics, Inc. |
| MK-1167primarySmall molecule | PAM | EC50 1.3 uM | Phase 2Alzheimer's disease | Merck & Co., Inc. |